Acid-Promoted Reaction of ResVeratrol with Nitrite
as inhibitors of specific enzymes such as cyclooxygenase,3,4 1a
has been shown to be an efficient scavenger of cytotoxic oxygen
and nitrogen species.5-9 Studies of structure-activity relation-
ships indicate that the antioxidant activity of 1a stems from the
peculiar oxygenation pattern on the planar stilbenic skeleton,
featuring as a crucial determinant of the radical scavenger
activity the 4′-OH group, synergistically supported by the 3-
and 5-OH groups on the resorcin moiety. The efficiency of the
4′-OH group as a hydrogen donor is enhanced by the trans
double bond, which increases both its acidity10 and the resonance
stabilization energy of the phenoxyl radical derived from H-atom
abstraction, as confirmed by semiempirical (PM3)11 and DFT12-14
analysis.
considering that NO-derived species are important mediators/
contributory factors in the inflammatory response and in
carcinogenesis.22 The major physiologic metabolite of NO is
nitrite (NO2-), which is present at high levels (30-210 µM) in
saliva and is also found in polluted drinking waters, vegetables
(e.g. spinaches), fertilizers, and preserved/pickled meats.23,24
Within the stomach and other acidic compartments supporting
nitrous acid (HNO2) formation,25 NO2- may cause nucleobase
deamination and interstrand cross-link formation and production
of mutagenic N-nitrosamines.26 Determining the susceptibility
of 1a to react with acidic NO2- and the identity of the reaction
products is therefore of particular interest to predict the possible
transformations and fate of 1a in the stomach in the presence
-
of high NO2 levels. In this connection it is worth noting that
1b has recently been shown to react efficiently with acidic nitrite
via a regioselective nitration at the double bond sector.27 Studies
of the nitr(os)ation chemistry of 1a are also expected to provide
a convenient entry to novel stilbene derivatives of potential
synthetic and pharmacological interest, e.g. in the field of
cyclooxygenase inhibitors and antiestrogenic compounds.3,4,28
This study describes the isolation and structural characteriza-
tion of the main products formed by acid-promoted reaction of
1a with NO2- under mild conditions, with the view to filling a
major gap in the chemistry of this bioactive stilbene and to
gaining an improved background for further studies of the
biological activity of this phytoalexin. Further interest of this
study stems from the potential bioactivity of the oxidation/
nitration products of 1a against phytopathogenic fungi which
is currently under scrutiny.
Because of the central relevance to the antioxidant activity
of 1a as well as to the process of biotransformation by the plant
pathogens into a range of oligomer species,15-17 the oxidation
chemistry of 1a has been the subject of considerable interest,
and several aspects have been clarified.18-20 Little is known,
by contrast, on the reaction of 1a with reactive nitrogen species
derived from nitric oxide (NO),21 the only relevant paper dealing
with the peroxynitrite-induced conversion to oxidation products.5
This represents a considerable gap in stilbene chemistry
Results and Discussion
(2) Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.;
Beecher, C. W. W.; Fong, H. H. S.; Farnsworth, N. R.; Kinghorn, A. D.;
Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Science 1997, 275, 218-220.
(3) Murias, M.; Handler, N.; Erker, T.; Pleban, K.; Ecker, G.; Saiko, P.;
Szekeres, T.; Ja¨ger, W. Bioorg. Med. Chem. 2004, 12, 5571-5578.
(4) Szewczuk, L. M.; Fori, L.; Stivala, L. A.; Penning, T. M. J. Biol.
Chem. 2004, 279, 22727-22737.
Acid-Promoted Reaction of 1a with NO2-. Product Char-
acterization. In a first series of experiments 1a (1 × 10-3 M)
-
was reacted with NO2 (5 molar equiv) in 0.1 M phosphate
buffer, pH 3.0. Reverse phase HPLC analysis of the reaction
mixture after 3 h indicated complete substrate consumption and
the presence of a complex pattern of products (Figure 1, plot
A), two of which (tR 29.2, product V, and tR 37.9 min, product
VII) displayed intense UV absorption at 320 nm.
(5) Brito, P.; Almeida, L. M.; Dinis, T. C. P. Free Radical Res. 2002,
36, 621-631.
(6) Lorentz, P.; Roychowdhury, S.; Engelmann, M.; Wolf, G.; Horn, T.
F. W. Nitric Oxide 2003, 9, 64-76.
(7) Burkitt, M. J.; Duncan, J. Arch. Biochem. Biophys. 2000, 381, 253-
263.
The complexity of the reaction mixture was confirmed by
TLC analysis of the ethyl acetate extractable fraction which
showed seven bands at Rf 0.36, 0.40, 0.48, 0.55, 0.69, 0.78,
and 0.84, two of which (Rf 0.36 and 0.55) exhibited a marked
bathochromic shift on exposure to alkali. At lower concentra-
tions of both 1a (2.5 × 10-5 M) and NO2- (8 molar equiv added
with stirring over 2 h at 15 min intervals of time), that is, under
conditions aimed to model interactions that may occur in the
gastric compartment during digestion following continuous
elevated nitrite intake, the product pattern was slightly different
(Figure 1, plot B). In particular, formation of VII and the product
(8) Olas, B.; Nowak, P.; Kolodziejczyk, J.; Ponczek, M.; Wachowicz,
B. J. Nutr. Biochem. 2006, 17, 96-102.
(9) Amorati, R.; Ferroni, F.; Pedulli, G. F.; Valgimigli, L. J. Org. Chem.
2003, 68, 9654-9658.
(10) Caruso, F.; Tanski, J.; Villegas-Estrada, A.; Rossi, M. J. Agric. Food
Chem. 2004, 52, 7279-7285.
(11) Stivala, L. A.; Savio, M.; Carafoli, F.; Perucca, P.; Bianchi, L.; Maga,
G.; Forti, L.; Pagnoni, U. M.; Albini, A.; Prosperi, E.; Vannini, V. J. Biol.
Chem. 2001, 276, 22586-22594.
(12) Leopoldini, M.; Marino, T.; Russo, N.; Toscano, M. J. Phys. Chem.
A 2004, 108, 4916-4922.
(13) Cao, H.; Pan, X.; Li, C.; Zhou, C.; Deng, F.; Li, T. Bioorg. Med.
Chem. Lett. 2003, 13, 1869-1871.
(14) Amorati, R.; Lucarini, M.; Mugnaini, V.; Pedulli, G. F.; Roberti,
M.; Pizzirani, D. J. Org. Chem. 2004, 69, 7101-7107.
(15) Cichewicz, R. H.; Kouzi, S. A.; Hamann, M. T. J. Nat. Prod. 2000,
63, 29-33.
(22) Ohshima, H.; Tatemichi, M.; Sawa, T. Arch. Biochem. Biophys.
2003, 417, 3-11.
(23) Duncan, C.; Dougall, H.; Johnston, P.; Green, S.; Brogan, R.; Leifert,
C.; Smith, L.; Golden, M.; Benjamin, N. Nat. Med. 1995, 1, 546-551.
(24) Coss, A.; Cantor, K. P.; Reif, J. S.; Lynch, C. F.; Ward, M. H. Am.
J. Epidemiol. 2004, 159, 693-701.
(25) Samouliov, A.; Kuppusamy, P.; Zweier, J. L. Arch. Biochem.
Biophys. 1998, 357, 1-7.
(26) Bartsch, H.; Oshima, H.; Pignatelli, B.; Calmels, S. Pharmacoge-
netics 1992, 2, 272-277.
(27) De Lucia, M.; Panzella, L.; Crescenzi, O.; Napolitano, A.; Barone,
V.; d′Ischia, M. Bioorg. Med. Chem. Lett. 2006, 16, 2238-2242.
(28) Gehm, B. D.; McAndrews, J. M.; Chien, P. Y.; Jameson, J. L. Proc.
Natl. Acad. U.S.A. 1997, 94, 14138-14143.
(16) Huang, K. S.; Lin, M.; Yu, L. N.; Kong, M. Tetrahedron 2000, 56,
1321-1329.
(17) Breuil, A.-C.; Adrian, M.; Pirio, N.; Meunier, P.; Bessis, R.; Jeandet,
P. Tetrahedron Lett. 1998, 39, 537-540.
(18) Nicotra, S.; Cramarossa, M. R.; Mucci, A.; Pagnoni, U. M.; Riva,
S.; Forti, L. Tetrahedron 2004, 60, 595-600.
(19) Sako, M.; Hosokawa, H.; Ito, T.; Iinuma, M. J. Org. Chem. 2004,
69, 2598-2600.
(20) del C. Pinto, M.; Garc´ıa-Barrado, J. A.; Mac´ıas, P. J. Agric. Food
Chem. 2003, 51, 1653-1657.
(21) Eiserich, J. P.; Patel, R. P.; O′Donnell, V. B. Mol. Aspects Med.
1998, 19, 221-357.
J. Org. Chem, Vol. 71, No. 11, 2006 4247